A Tetanus Vaccine That Kills Babies?... 
#161736
21 y
11,927
The Easier Way to Juice Fast
Reduces cleansing reactions and hunger.
Original Hulda Clark
Hulda Clark Cleanses
A Tetanus Vaccine That Kills Babies? WHO Did It? WHO
Did It!
WASHINGTON, Dec. 9 /PRNewswire/ --
In the final ad of a 13-week campaign to educate Bill Gates on population elimination,
American Life League tells Gates that his recent $26 million gift to end maternal tetanus may not be what he thinks it is.
The tetanus program -- funded by the Gates Foundation and reportedly provided by the World Health Organization -- bears a striking resemblance to a previous tetanus program in which the WHO was deeply involved.
The previous program, conducted in the Philippines in 1995, involved only women in their child-bearing years. The women were given the tetanus vaccine combined with a chemical called Human Chorionic Gonadotrophin (HCG)
to create an anti-pregnancy agent. This caused the deaths of many babies.
The BBC, in conjunction with the Philippine Department of Health and the Philippine Medical Association, reported that many Filipino women suffered spontaneous abortions due to the vaccine, which creates an immune response to pregnancy in the mother's body.
The BBC report has never aired in the United States.
"This is the world of population elimination," said ALL president Judie Brown. "And Bill Gates has fallen right into the lies. Most likely, Gates believes his funds are helping sick women and children, but in reality they're creating unimaginable suffering."
The current Gates funded program, involving the WHO in several developing countries, is once again aimed only at women in their child-bearing years.
"Considering that ALL has not materially benefited from our ad campaign to educate Bill Gates on population elimination, there can really be only one reason we've taken such measures to reach him," said Brown. "We're telling the truth."
ALL's campaign and information on global population can be found online at www.billgateseducate.com
Judie Brown is president of American Life League, the nation's largest pro-life educational organization with more than 300,000 supporters. ALL / P.O. Box 1350 / Stafford, VA 22555 / 540-659-4171 / http://www.all.org
SOURCE American Life League
CO: American Life League; World Health Organization
ST: District of Columbia, Philippines
IN: MTC
SU: 12/09/1999 09:45 EST http://www.prnewswire.com
More
- New Vaccines Laced With Birth-Contro... #163617
21 y
11,382
This is a reply to # 368,716Is The Tetanus Toxoid Vaccine Tampered?
Are New Vaccines Laced With Birth-Control Drugs?
By James A. Miller, special correspondent for Human Life International. Copyright 1995.
During the early 1990s, the World Health Organization (WHO) has been overseeing massive vaccination campaigns against tetanus in a number of countries, among them Nicaragua, Mexico, and the Philippines. In October 1994, HLI received a communication from its Mexican affiliate, the Comite' Pro Vida de Mexico, regarding that country's anti-tetanus campaign. Suspicious of the campaign protocols, the Comite' obtained several vials of the vaccine and had them analyzed by chemists. Some of the vials were found to contain human chorionic gonadotrophin (hCG), a naturally occurring hormone essential for maintaining a pregnancy.
hCG and Anti-hCG Antibodies
In nature the hCG hormone alerts the woman's body that she is pregnant and causes the release of other hormones to prepare the uterine lining for the implantation of the fertilized egg. The rapid rise in hCG levels after conception makes it an excellent marker for confirmation of pregnancy: when a woman takes a pregnancy test she is not tested for the pregnancy itself, but for the elevated presence of hCG.
However, when introduced into the body coupled with a tetanus toxoid carrier, antibodies will be formed not only against tetanus but also against hCG. In this case the body fails to recognize hCG as a friend and will produce anti-hCG antibodies. The antibodies will attack subsequent pregnancies by killing the hCG which naturally sustains a pregnancy; when a woman has sufficient anti-hCG antibodies in her system, she is rendered incapable of maintaining a pregnancy.(1)
HLI reported the sketchy facts regarding the Mexican tetanus vaccines to its World Council members and affiliates in more than 60 countries.(2) Soon additional reports of vaccines laced with hCG hormones began to drift in from the Philippines, where more than 3.4 million women were recently vaccinated. Similar reports came from Nicaragua, which had conducted its own vaccination campaign in 1993.
The Known Facts
Here are the known facts concerning the tetanus vaccination campaigns in Mexico and the Philippines:
* Only women are vaccinated, and only the women between the ages of 15 and 45. (In Nicaragua the age range was 12-49.) But aren't men at least as likely as young women to come into contact with tetanus? And what of the children? Why are they excluded?
* Human chorionic gonadotrophin (hCG) hormone has been found in the vaccines. It does not belong there -- in the parlance of the O.J. Simpson murder trial, the vaccine has been "contaminated."
* The vaccination protocols call for multiple injections -- three within three months and a total of five altogether. But, since tetanus vaccinations provide protection for ten years or more, why are multiple inoculations called for?(3)
* WHO has been actively involved for more than 20 years in the development of an anti-fertility vaccine utilizing hCG tied to tetanus toxoid as a carrier -- the exact same coupling as has been found in the Mexican-Philippine-Nicaragua vaccines.(4)
The Anti-Fertility Gang
Allied with the WHO in the development of an anti-fertility vaccine (AFV) using hCG with tetanus and other carriers have been UNFPA, the UN Development Programme (UNDP), the World Bank, the Population Council, the Rockefeller Foundation, the All India Institute of Medical Sciences, and a number of universities, including Uppsala, Helsinki, and Ohio State.(5) The U.S. National Institute of Child Health and Human Development (part of NIH) was the supplier of the hCG hormone in some of the AFV experiments.(6)
The WHO begain its "Special Programme" in human reproduction in 1972, and by 1993 had spent more than $356 million on "reproductive health" research.(7) It is this "Programme" which has pioneered the development of the abortificant vaccine. Over $90 million of this Programme's funds were contributed by Sweden; Great Britain donated more than $52 million, while Norway, Denmark and Germany kicked in for $41 million , $27 million, and $12 million, respectively. The U.S., thanks to the cut-off of such funding during the Reagan-Bush administrations, has contributed "only" $5.7 million, including a new payment in 1993 by the Clinton administration of $2.5 million. Other major contibutors to the WHO Programme include UNFPA, $61 million; the World Bank, $15.5 million; the Rockefeller Foundation, $2.5 million; the Ford Foundation, over $1 million; and the IDRC (International Research and Development Centre of Canada), $716.5 thousand.
WHO and Philippine Health Department Excuses
When the first reports surfaced in the Philippines of tetanus toxoid vaccine being laced with hCG hormones, the WHO and the Philippine Department of Health (DOH) immediately denied that the vaccine contained hCG. Confronted with the results of laboratory tests which detected its presence in three of the four vials of tetanus toxoid examined, the WHO and DOH scoffed at the evidence coming from "right-to-life and Catholic" sources. Four new vials of the tetanus vaccine were submitted by DOH to St. Luke's (Lutheran) Medical Center in Manila -- and all four vials tested positive for hCG!
From outright denial the stories now shifted to the allegedly "insignificant" quantity of the hCG present; the volume of hCG present is insufficient to produce anti-hCG antibodies.
But new tests designed to detect the presence of hCG antibodies in the blood sera of women vaccinated with the tetauns toxoid vaccine were undertaken by Philippine pro-life and Catholic groups. Of thirty women tested subsequent to receiving tetanus toxoid vaccine, twenty-six tested positive for high levels of anti-hCG! If there were no hCG in the vaccine, or if it were present in only "insignificant" quantities, why were the vaccinated women found to be harboring anti-hCG antibodies? The WHO and the DOH had no answers.
New arguments surfaced: hCG's apparent presence in the vaccine was due to "false positives" resulting from the particular substances mixed in the vaccine or in the chemicals testing for hCG. And even if hCG was really there, its presence derived from the manufacturing process.
But the finding of hCG antibodies in the blood sera of vaccinated women obviated the need to get bogged down in such debates. It was no longer necessary to argue about what may or may not have been the cause of the hCG presence, when one now had the effect of the hCG. There is no known way for the vaccinated women to have hCG antibodies in their blood unless hCG had been artificially introduced into their bodies!
Why A Tetanus Toxoid "Carrier"?
Because the human body does not attack its own naturally occurring hormone hCG, the body has to be fooled into treating hCG as an invading enemy in order to develop a successful anti-fertility vaccine utilizing hCG antibodies. A paper delivered at the 4th International Congress of Reproductive Immunology (Kiel, West Germany, 26-29 July 1989) spelled it out: "Linkage to a carrier was done to overcome the immunological tolerance to hCG."(8)
Vaccine Untested by Drug Bureau
After the vaccine controversy had reached a fever pitch, a new bombshell exploded; none of the three different brands of tetanus vaccine being used had ever been licensed for sale and distribution or registered with the Philippine Bureau of Food and Drugs (BFAD), as required by law. The head of the BFAD lamely explained that the companies distributing these brands "did not apply for registration."(9) The companies in question are Connaught Laboratories Ltd. and Intervex, both from Canada, and CSL Laboratories from Australia.
It seemed that the BFAD might belatedly require re-testing, but the idea was quickly rejected when the Secretary of Health declared that, since the vaccines had been certified by the WHO -- there they are again! -- there was assurance enough that the "vaccines come from reputable manufacturers."(10)
Just how "reputable" one of the manufacturers might be is open to some question. In the mid-`80s Connaught Laboratories was found to be knowingly distributing vials of AIDS-contaminated blood products.(11)
Epilogue
At this juncture, evidence is beginning to appear from Africa.(12) HLI has called for a Congressional investigation of the situation, inasmuch as nearly every agency involved in the development of an anti-fertility vaccine is funded, at least in part, with U.S. monies.
NOTES:
(1) "Abortifacient vaccines loom as new threat," HLI Reports, November 1993, pp. 1-2.
(2) World Council Reports, 28 November 1994, pp. 4-5.
(3) A call placed by this writer on 5 May 1995 to the Montgomery County (Maryland) Health Department, Epidemology Division -- Infectious Diseases -- Adult Immunizations, elicited the following information:
Q. For how long a time does the tetanus vaccination offer protection?
A. 10 years.
Q. Have you ever heard of any adult requiring three tetanus vaccinations within a 3 or 4 month time period, and a total of 5
vaccinations in all within a year or so?
A. Whaaaat! Never. No way!
Reports from the Philippines appear to confirm the 10-year immunity afforded by tetanus toxoid vaccinations: prior to the campaigns begun in 1993, the so-called booster shots were given only every 10 years.
(4) More than a score of articles, many written by WHO researchers, document WHO's attempts to create an anti-fertility vaccine utilizing tetanus toxoid as a carrier. Some leading articles include:
"Clinical profile and Toxicology Studies on Four Women Immunized with Pr-B-hCG-TT," Contraception, February, 1976, pp. 253-268.
"Observations on the antigenicity and clinical effects of a candidate antipregnancy vaccine: B-subunit of human chorionic
gonadotropin linked to tetanus toxoid," Fertility and Sterility, October 1980, pp. 328-335.
"Phase 1 Clinical Trials of a World Health Organisation Birth Control Vaccine," The Lancet, 11 June 1988, pp. 1295-1298.
"Vaccines for Fertility Regulation," Chapter 11, pp. 177-198, Research in Human Reproduction, Biennial Report (1986-1987),
WHO Special Programme of Research, Development and Research Training in Human Reproduction (WHO, Geneva 1988).
"Anti-hCG Vaccines are in Clinical Trials," Scandinavian Journal of Immunology, Vol. 36, 1992, pp. 123-126.
(5) These institutional names are garnered from the journal articles cited in the previous footnote.
(6) Lancet, 11 June 1988, p. 1296.
(7) Challenges in Reproductive Health Research, Biennial Report 1992-1993, World Health Organization, Geneva, 1994, p. 186.
(8) G.P. Talwar, et al, "Prospects of an anti-hCG vaccine inducing antibodies of high affinity...(etc)," Reproductive Technology 1989, Elsevier Science Publishers, 1990, Amsterdam, New York, p. 231.
(9) "3 DOH vaccines untested by BFAD," The Philippine Star, 4 April 1995, pp. 1, 12.
(10) "BFAD junks re-testing of controversial shot," Manila Standard, 7 April 1995; "DOH: Toxoid vaccines are safe," The Philippine Star, 7 April 1995.
(11) "Ottawa got blood tainted by HIV." Ottawa Citizen, 4 April 1995.
(12) A nearly two-year old communique from Tanzania tells a familiar story: tetanus toxoid vaccinations, five in all, given only to women aged 15-45.
Nigeria, too, may have been victimized; see The Lancet, 4 June 1988, p. 1273.
Credit: Copyright June/July 1995 by Human Life International. This article was originally published in HLI Reports, Human Life International, Gaithersburg, Maryland; June/July 1995, Volume 13, Number 8. Permission to reprint granted to New Atlantean News.http://www.akha.org/admin/documents/tetlacedwithdrug.htm
More
- REPORTS OF CONTAMINATED TETANUS TOXO... #166850
21 y
14,430
This is a reply to # 368,717Press Release WHO/56 - 19 July 1995
REPORTS OF CONTAMINATED TETANUS TOXOID VACCINE ARE FALSE, SAYS WHO
Disturbing reports are reaching the World Health Organization (WHO) from Mexico, Nicaragua, Tanzania, and the Philippines, that the tetanus toxoid (TT) vaccine has been contaminated with a substance - human chorionic gonadotrophin (hCG) - that is claimed to reduce women's fertility.
"These rumours are completely false and are totally without any scientific basis", says Dr Jong-Wock Lee, Director of the WHO Global Programme for Vaccines and Immunization. "They are categorically denied by the Governments responsible for administering the vaccine, by the vaccine manufacturers, by UNICEF (which provides much of the TT vaccine used in the world) and by the World Health Organization".
WHO and UNICEF insist it would be unethical and forcefully rejected by them, if any vaccine vials being used contained substances other than the vaccine itself.
The reports originated in the Philippines, where a pro-life group submitted a batch of vaccine to a totally inappropriate test which produced a false positive result.
The World Health Organization has followed up this initial test by conducting independent testing to assess whether hCG is present in vials of tetanus toxoid vaccine produced by different manufacturers.
All tests were either negative or produced results with no significance. Indeed, tests conducted by the Human Co of Hungary showed even higher results in tap water from the laboratory and from the hospital than from the vaccine itself.
Professor Salvatore Mancuso, Chairman of the Faculty of Medicine and Surgery of the Catholic University of the Sacred Heart in Rome, Italy, commented that the positive test results should be considered "as an artefact rather than a true value". The other testing laboratories, St Lukes in the Philippines which tested four lots, the Food and Drug Administration of the USA which tested four samples (two from the vaccine used in Mexico, one from a US producer and one from a European supplier to UNICEF) and two samples from Tanzania tested by the Netherlands Government all produced results that were negative or of no significance.
The summary of these findings is that, without exception, when interpreted by independent laboratory staff, including those in the Philippines that conducted the original tests which started the rumour, all samples of tetanus toxoid vaccine have proved negative for hCG.
At present, an estimated 700,000 cases of neonatal tetanus and 60,000 cases of maternal tetanus are being prevented each year through immunization.
"False rumours concerning the safety and purpose of vaccines, such as the tetanus toxoid vaccine given to adult women, may create a loss of faith in these vaccines, result in lower immunization coverage and lead to a wholly unnecessary loss of life from the diseases they effectively and safely prevent," comments Dr Lee.
______________
For further information please contact Valery Abramov, Health Communications and Public Relations, WHO, Geneva. Tel. (41 22) 791 2543. Fax. (41 22) 4858.
http://www.who.int/archives/inf-pr-1995/pr95-56.html
- Re: REPORTS OF CONTAMINATED TETANUS ... mama23
20 y
14,652
This is a reply to # 368,718
http://www.vaccinationnews.com/DailyNews/February2002/FutProsVaxFertility.htm
http://news.bmn.com/hmsbeagle/120/notes/feature7
Future Prospects for Vaccines to Control Fertility
by Peter J. Delves, Torben Lund, and
Ivan M. Roitt
Feature Six
This article will also appear in Trends in Immunology.
Posted February 15, 2002 · Issue 120
Abstract
Vaccination is used routinely to protect against infectious disease and is being explored increasingly as a method of protection against tumors. Also, it has been established that vaccination using antigens associated with reproduction can protect against undesired pregnancy. Substantial progress over the past decade suggests that, if the remaining immunological and socioeconomic issues can be resolved, antifertility vaccines could be a valuable, additional method of family planning.
The human population exceeded six billion in October 1999, double the population in 1960. It is growing currently by 77 million people per year (United Nations Population Information Network). Such an alarming rise reflects the fact that, at a global level, 40% of couples of reproductive age do not practice any form of contraception currently [1]. Approximately one half of the one million new pregnancies each day are unintended, and in the United States, 46% of women have had at least one elective abortion by the end of their child-bearing years [2]. There is a clear need for the increased use of contraception and a wider choice of contraceptive options. In addition to humans, reduced fertility is often desirable in animal populations [3,4]. One approach towards additional methods of fertility control is the development of vaccines that elicit an antibody response capable of neutralizing hormones, or sperm or egg antigens that are essential for reproduction (figure 1). It seems probable that this approach will become accepted generally for veterinary use. However, although the efficacy of an antifertility vaccine in humans has been established [5], several issues are currently being addressed before these vaccines can be employed routinely for human family planning.
Reversibility and Safety
In the past, concerns have been raised that antifertility vaccines might produce permanent infertility. However, it has been a general finding that, in the absence of boosting, protection from pregnancy is afforded only over a period of weeks or months, rather than years. Indeed, the generation of longer term immune responses will be a necessary improvement to current antifertility vaccines. To date, human phase I and phase II trials have involved mostly, but not exclusively, human chorionic gonadotropin (hCG)-based vaccines [6,7]. The anti-hCG vaccines have used the betachain of hCG [7], a heterospecies dimer of human betachain with sheep alphachain [7,8] or a Cterminal peptide (CTP) from the betachain [6,9]. Generally, the vaccines have proved to be safe in these trials, but long-term safety of the vaccine over several years in large numbers of people will also need to be established eventually.
The Problem of Low Responders
The only successful human phase II trial carried out to date used the heterospecies dimer [8]; in this study, 80% of vaccinated females produced protective levels of antibody. Unless pre-screening to identify adequate responders is used, a significant improvement in the number of individuals mounting the necessary level of response is required. Indeed, although the U.S. company Zonagen, Inc. entered a collaborative option agreement with Wyeth-Ayerst laboratories in 2000, regarding the development of a human oocyte zona-pellucida-based contraceptive vaccine, the agreement was terminated in September 2001 and Zonagen suspended further research into the vaccine, because of an inability to induce sufficient antibody titers for a contraceptive effect in all of the baboons in the trial. Much more so than for veterinary antifertility vaccines, the human user will need to be sure that the contraceptive vaccine will be effective for them. Promiscuous T-cell epitopes might hold the key.
Is the Vaccine Approach Acceptable?
One issue that has been raised is that the development of nonbarrier methods of contraception is detrimental to the fight against sexually transmitted diseases. Education regarding the use of appropriate methods for individual lifestyles is of paramount importance with all types of contraception. In fact, it might be possible eventually to include additional antigens within the vaccine formulation that would provoke a protective mucosal immune response against organisms causing sexually transmitted diseases. Some antifertility vaccines, including those based upon hCG, act post-fertilization and therefore, are not acceptable to all people. Nonetheless, several currently available methods of contraception, such as intrauterine devices and some forms of hormonal contraception, can act post-fertilization also but are used by large numbers of people. Vaccines that act pre-fertilization would probably be acceptable to most people, but only if a high level of safety and efficacy can be demonstrated convincingly.
The Future of Clinical Trials
Irrespective of the type of vaccine, vaccine development will require substantial sums of money. Governments, nongovernmental organizations, and the pharmaceutical industry will need to be convinced that such an approach is likely to become an acceptable method of birth control. To date, clinical trials have been carried out largely under the auspices of the government of India and, separately, the World Health Organisation (WHO). Currently, the government of India is supporting continuing research, but further clinical trials are not planned until the vaccines have undergone further refinement. The WHO-sponsored program ceased further trials whilst a new version of their CTP vaccine, which now includes a loop peptide from the hCG betachain also [6], was developed. The relevant program committee is due to meet in the near future to discuss possible clinical trials with the new vaccine.
Concluding Remarks
Although the further refinement of vaccines aimed at controlling fertility is necessary, it would seem probable that an efficacy comparable to that of many of the current family-planning methods will be achievable. More evidence regarding the long-term safety of this approach will only accumulate if extensive clinical trials are carried out. This will require enthusiastic political and commercial commitment to develop such vaccines for general use.
Matt Morrow is a freelance illustrIator based in Omaha, Nebraska.
- Re: REPORTS OF CONTAMINATED TETANUS ... mama23
20 y
14,652
- REPORTS OF CONTAMINATED TETANUS TOXO... #166850
21 y
14,430
- New Vaccines Laced With Birth-Contro... #163617
21 y
11,382
Share:
Translate This Page: